Pro forma gross profit for the quarter was $15 million, yielding a pro forma gross margin of 62.9% compared to 68.0% for fiscal Q1 ended March 31, 2025, with the difference primarily related to tissue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results